Full-Time

Medical Science Liaison

Msl, Oncology

Updated on 11/19/2024

BillionToOne

BillionToOne

201-500 employees

Molecular diagnostics for prenatal and oncology testing

Biotechnology
Healthcare

Compensation Overview

$180k - $200kAnnually

+ Equity Options + Corporate Bonus Program

Junior, Mid

Remote in USA

Preferred time zones: US Central or Eastern.

Category
Physicians & Surgeons
Medical, Clinical & Veterinary
Requirements
  • Advanced degree in a related science or health discipline
  • 2+ years of experience as a Medical Science Liaison or similar position in oncology, diagnostic experience preferred
  • Expertise in discussing scientific content and context to multiple audiences
  • Excellent communication and interpersonal skills
  • Ability to travel up to 70%
Responsibilities
  • Serve as a key liaison to Health Care Providers (HCPs) in the oncology space regarding liquid biopsy and BillionToOne products
  • Serve as a key member of the BillionToOne Oncology Medical Affairs team
  • Develop and maintain relationships with key opinion leaders (KOLs) by engaging in scientific exchange with medical and scientific partners
  • Support commercial team by providing impactful information that enhances the value and proper use of BillionToOne products
  • Respond to HCP customer inquiries to provide focused and balanced clinical and scientific information that supports the appropriate use of or clinically differentiates BillionToOne's products and services
  • Contribute to development of provider and patient educational products
  • Adhere to internal standard processes and comply with regulatory and compliance requirements
  • Other duties as may be assigned

BillionToOne specializes in molecular diagnostics within the healthcare sector, focusing on prenatal screening and oncology testing. Their proprietary QCT technology allows for the detection and quantification of diseases by identifying minute variations in DNA at a single base-pair level. The company offers two main products: Northstar Select™, which helps determine the best initial therapy for patients, and Northstar Response™, which tracks the effectiveness of that therapy. Unlike many competitors, BillionToOne emphasizes accuracy and accessibility in molecular testing, providing diagnostic services directly to healthcare providers. Their goal is to enhance the precision and efficiency of molecular testing, ultimately making a positive impact on healthcare.

Company Stage

Series D

Total Funding

$380.2M

Headquarters

Menlo Park, California

Founded

2016

Growth & Insights
Headcount

6 month growth

12%

1 year growth

23%

2 year growth

77%
Simplify Jobs

Simplify's Take

What believers are saying

  • The recent $130M Series D funding round, led by PremjiInvest, positions BillionToOne for significant growth and expansion.
  • Partnerships with major companies like Johnson & Johnson enhance their credibility and market reach.
  • The appointment of Ross Taylor as CFO brings seasoned financial leadership, supporting the company's hypergrowth trajectory.

What critics are saying

  • The competitive landscape in molecular diagnostics is intense, requiring continuous innovation to maintain a leading position.
  • Dependence on healthcare providers for revenue could be impacted by changes in healthcare policies or economic downturns.

What makes BillionToOne unique

  • BillionToOne's QCT technology offers single base-pair resolution, providing unparalleled accuracy in molecular diagnostics.
  • Their focus on both prenatal screening and oncology testing allows them to address critical healthcare needs with specialized products like Northstar Select™ and Northstar Response™.
  • The company's mission-driven culture and commitment to accessibility set them apart in the biotech industry.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Competitive pay

Retirement savings package

Parental leave

Free snacks & lunches

Medical, dental, & vision premiums

On campus perks

Free-on-site EV charging